Dr. Nikravesh joins RiboFlare as EVP & Senior VP.

 

Riboflare, Inc. (Nevada Corp) is a point-of-care Company for on-site clinical diagnostics targeting infectious disease, oral microbiome, gut microbiome, and bio-threat. Ribbflare provides predictive models of disease progression including diabetes, cancer, and inflammatory bowel disease to name a few. Riboflare technology is based on patented innovative nano-particles and microfluid systems-based technologies. This cutting edge technologies enable our innovative solution for microbiome molecular imaging based on multiplexed live cell assay such as oral microbiome and infectious disease.